2024 |
Akero Therapeutics Inc
|
Independent Director |
- |
- |
2024 |
Olema Pharmaceuticals Inc
|
Independent Director |
- |
- |
2023 |
Akero Therapeutics Inc
|
Independent Director |
578.6 K |
328.6 % |
2022 |
Akero Therapeutics Inc
|
Independent Director |
135.0 K |
-47.7 % |
2022 |
Olema Pharmaceuticals Inc
|
Independent Director |
105.9 K |
-75.4 % |
2021 |
Alx Oncology Holdings Inc
|
- |
514.6 K |
46.6 % |
2021 |
Olema Pharmaceuticals Inc
|
Independent Director |
430.0 K |
-45.8 % |
2021 |
Akero Therapeutics Inc
|
Independent Director |
258.1 K |
4.0 % |
2021 |
Alx Oncology Holdings Inc
|
Independent Director |
- |
- |
2020 |
Olema Pharmaceuticals Inc
|
Independent Director |
792.9 K |
- |
2020 |
Alx Oncology Holdings Inc
|
Independent Director |
351.1 K |
- |
2020 |
Akero Therapeutics Inc
|
Independent Director |
248.2 K |
-34.1 % |
2019 |
Akero Therapeutics Inc
|
Independent Director |
376.6 K |
- |
2019 |
Alx Oncology Holdings Inc
|
Independent Director |
- |
- |
2019 |
Olema Pharmaceuticals Inc
|
Independent Director |
- |
- |
2018 |
Akero Therapeutics Inc
|
Independent Director |
- |
- |